查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1786450

DLIF 和 XLIF植入的全球市场

DLIF and XLIF Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 278 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，DLIF 和 XLIF植入的全球市场规模将达到 18 亿美元

全球DLIF和XLIF植入市场规模预计在2024年为15亿美元，预计到2030年将达到18亿美元，2024年至2030年的复合年增长率为2.6% 。退化性疾病应用是本报告分析的细分领域之一，预计其复合年增长率为3.1%，到分析期结束时市场规模将达到8.218亿美元。椎间滑脱应用在分析期间内的复合年增长率预计为2.6%。

美国市场规模估计为 4.209 亿美元，中国市场预计复合年增长率为 5.0%

预计到2024年，美国的DLIF和XLIF植入市场规模将达到4.209亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到3.476亿美元，在2024-2030年的分析期间内，复合年增长率为5.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为0.9%和1.9%。在欧洲，预计德国市场的复合年增长率为1.4%。

全球 DLIF 和 XLIF植入市场 - 主要趋势和驱动因素摘要

微创脊椎手术的兴起是否会推动 DLIF 和 XLIF植入的需求？

过去十年，脊椎外科领域经历了重大的模式转移，这得益于临床和患者对微创手术 (MIS) 日益增长的偏好。其中，最具突破性的创新是直接侧方椎间融合术 (DLIF) 和极侧方椎间融合术 (XLIF)，这两种手术允许外科医生从侧方入路而非传统的前入路或后入路进入腰椎。这些手术旨在最大限度地减少肌肉和组织损伤、减少术中失血、缩短住院时间并加快患者康復。这些手术越来越受欢迎，主要是因为全球脊椎疾病发生率上升，尤其是在高龄化社会。随着人们寿命延长和老年仍保持积极的生活方式，腰椎退化性椎间盘病、椎间滑脱和脊椎狭窄等疾病变得越来越常见。 DLIF 和 XLIF植入正日益受到青睐，因为它们在手术过程中对脊椎稳定和復位起到关键作用，能够成功融合併最大程度地降低患者的患病率。医院和门诊手术中心也在投资设备和培训以支持这些手术，这反映出各机构普遍致力于微创治疗模式。外科医生越来越倾向于使用这些方法，不仅因为它们具有临床益处，还因为它们可以改善工作流程并缩短手术时间。此外，这些植入通常与最先进的术中神经监测和影像引导结合使用，以提高手术精确度并降低併发症风险。随着医疗相关人员不断采用和改进这些技术，对 DLIF 和 XLIF植入的需求预计将稳步增长，使它们成为未来脊椎融合手术不可或缺的一部分。

植入材料创新如何影响市场动态？

材料科学处于DLIF和XLIF植入市场创新的前沿，新成分和结构的进步显着改善了植入的性能和患者的预后。传统上，钛因其强度和生物相容性而成为首选材料，但其渗透性使得术后成像困难。这促使人们转向PEEK（聚醚醚酮）等材料，这种材料具有渗透性，并有助于术后骨癒合评估。此外，PEEK的弹性模数更接近天然骨，进而减少应力遮挡，促进更稳健的骨重塑。近年来，多孔钛以及PEEK与钛的混合材料因其能够平衡可见度、骨整合和结构完整性而广受欢迎。另一项突破性进展是利用3D列印技术製造具有客製化多孔结构的植入，这些植入物可以模拟鬆质骨，促进自然骨形成。这些积层製造的植入还可以根据患者特定的解剖学要求进行定制，从而改善贴合度并降低併发症风险。此外，许多公司正在采用奈米纹理和生物活性涂层等表面处理技术，以增强细胞黏附并促进骨整合。这些创新技术正在缩短癒合时间，并提高脊椎手术的长期成功率。随着植入设计的不断发展，人们的注意力转向多功能植入，这些植入物不仅具有机械稳定性，还具有生物学优势。临床研究开始证明这些先进材料具有卓越的疗效，影响医院和外科中心的采购决策。这项技术飞跃也得益于材料科学家、生物医学工程师和骨科医生之间的合作，旨在突破植入在现代脊椎护理中所能达到的极限。

医疗保健基础设施和报销政策的变化会改变市场准入吗？

全球医疗服务格局正在发生重大变化，这些变化对 DLIF 和 XLIF植入的采用产生了重大影响。在美国、德国和日本等已开发国家，完善的医疗基础设施和全面的保险覆盖使这些植入能够迅速融入常规外科手术中。在美国，医疗保险和私人保险公司提供优惠的报销政策，鼓励医院投资 DLIF 和 XLIF 手术所需的专业培训和设备。这种财政支持甚至使中型医疗机构也能够采用这些先进的手术。相反，在亚洲、拉丁美洲和中东的一些新兴市场，医疗保健系统处于不同的发展阶段，促进或阻碍了这些技术的采用。然而，这些地区正看到医疗服务现代化和扩大的明显趋势。政府正在大力投资医疗基础设施，私立医院连锁店正在激增，为日益壮大的中产阶级提供优质的脊椎手术。由国际脊椎学会和全球医疗技术公司主导的培训计画正在帮助提升当地外科医生在侧入路融合技术方面的技能，从而推动市场扩张。同时，报销模式也在不断发展，越来越多的国家转向以价值为基础的医疗，奖励 DLIF 和 XLIF 所特有的临床效果和成本效益。此外，门诊脊椎手术的兴起，尤其是在美国和西欧，正在加速可用于更短、侵入性更小手术的植入的需求。对捆绑式支付和分期报销的日益关注也鼓励医院选择可最大限度减少併发症和再入院率的植入解决方案。这些制度变化正在重塑 DLIF 和 XLIF植入的获取管道，使其更加普及，并扩大其在全球脊椎外科生态系统中的作用。

真正推动 DLIF 和 XLIF植入市场成长的因素是什么？

DLIF 和 XLIF植入市场的成长受到多种因素的驱动，这些因素与技术创新、人口变化、外科手术的不断发展以及最终用户的期望密切相关。其中一个最重要的驱动因素是退化性脊椎疾病和创伤性损伤的日益增多，这推动了对有效可靠的脊椎融合手术的需求。 DLIF 和 XLIF 手术以其微创特性而闻名，正迅速成为这些环境中的首选手术，从而推动了对其中所用植入的需求。手术导引、机器人辅助和术中影像的技术进步也是关键因素，因为这些工具可以实现高度精确的植入放置，改善临床结果并增强外科医生的信心。同样重要的是手术偏好的转变。骨科医生和神经外科医生越来越青睐侧入路，这可以避免严重的肌肉损伤并缩短住院时间。患者越来越要求手术能够提供更快的恢復、更少的疼痛和最小的疤痕，而 DLIF 和 XLIF 手术与合适的植入相结合，可以实现所有这些效果。门诊手术中心 (ASC) 和当天出院选项的趋势也推动了对支持更短、更有效率手术的植入的需求。此外，新兴企业和成熟的医疗技术公司进入这一细分市场，正在加强研发力度，从而产生针对特定病患小组、脊椎病理和外科医生偏好的更多样化和先进的产品。市场参与企业也专注于与医院和研究机构建立策略合作伙伴关係，以建立整合植入、器械、导航工具、培训模组等的综合程序生态系统。这些协同效应正在简化手术流程并增加医疗保健提供者的价值。最后，对数据主导结果和长期成本效益的日益重视，正在推动医疗机构青睐再手术率更低、患者满意度更高的植入系统，巩固了 DLIF 和 XLIF植入在全球脊椎移植市场的地位。

部分

用途（退化性疾病用途、椎间滑脱用途、脊椎用途、其他用途）；最终用途（医院最终用途、门诊病人设施最终用途）

受访公司范例

  • Alphatec Holdings, Inc.（ATEC Spine）
  • Aurora Spine Corporation
  • B. Braun Melsungen AG
  • Captiva Spine, Inc.
  • Centinel Spine, LLC
  • CoreLink, LLC
  • Curiteva
  • DePuy Synthes（Johnson & Johnson）
  • Exactech, Inc.
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Life Spine, Inc.
  • LDR Holding Corporation
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • SeaSpine Holdings Corporation
  • Spinal Elements, Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP30553

Global DLIF and XLIF Implants Market to Reach US$1.8 Billion by 2030

The global market for DLIF and XLIF Implants estimated at US$1.5 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Degenerative Disc Diseases Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$821.8 Million by the end of the analysis period. Growth in the Spondylolisthesis Application segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$420.9 Million While China is Forecast to Grow at 5.0% CAGR

The DLIF and XLIF Implants market in the U.S. is estimated at US$420.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.6 Million by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global DLIF and XLIF Implants Market - Key Trends & Drivers Summarized

Is the Rise of Minimally Invasive Spine Surgeries Fueling the Demand for DLIF and XLIF Implants?

Over the past decade, the field of spine surgery has witnessed a significant paradigm shift, with growing clinical and patient preference for minimally invasive surgical (MIS) techniques. Among the most transformative innovations are Direct Lateral Interbody Fusion (DLIF) and Extreme Lateral Interbody Fusion (XLIF), which allow surgeons to access the lumbar spine through a lateral approach rather than the traditional anterior or posterior route. These procedures are designed to minimize damage to muscles and tissues, reduce intraoperative blood loss, shorten hospital stays, and enable faster patient recovery. The increasing popularity of these techniques is largely driven by the global rise in spinal disorders, especially among the aging population. Conditions such as lumbar degenerative disc disease, spondylolisthesis, and spinal stenosis are becoming more prevalent as people live longer and maintain active lifestyles well into old age. DLIF and XLIF implants, which play a central role in stabilizing and realigning the spine during these procedures, are gaining momentum due to their ability to facilitate successful fusions with minimal patient morbidity. Hospitals and ambulatory surgical centers are also investing in equipment and training that support these techniques, reflecting a broader institutional commitment to less invasive care models. Surgeons are increasingly drawn to these approaches not only for their clinical benefits but also for improved workflow and reduced surgical times. Moreover, these implants are often used in combination with cutting-edge intraoperative neuromonitoring and imaging guidance, enhancing surgical accuracy and reducing the risk of complications. As medical professionals continue to adopt and refine these techniques, the demand for DLIF and XLIF implants is expected to grow steadily, making them integral to the future of spinal fusion surgeries.

How Are Innovations in Implant Materials Shaping Market Dynamics?

Material science is at the forefront of innovation in the DLIF and XLIF implants market, with new compositions and structural advancements significantly enhancing implant performance and patient outcomes. Traditionally, titanium was the material of choice due to its strength and biocompatibility, but its radiopaque nature made post-surgical imaging more difficult. This has led to a shift toward materials such as PEEK (polyether ether ketone), which offers radiolucency, allowing for easier post-operative assessments of bone fusion. Furthermore, PEEK's elastic modulus closely matches that of natural bone, reducing stress shielding and promoting healthier bone remodeling. In recent years, porous titanium and hybrid materials combining PEEK and titanium have gained popularity due to their ability to balance visibility, osteointegration, and structural integrity. Another groundbreaking development is the use of 3D printing technology to manufacture implants with customized porous architecture that mimics cancellous bone, which encourages natural bone in-growth. These additively manufactured implants can also be tailored to patient-specific anatomical requirements, improving fit and reducing the risk of complications. Additionally, many companies are incorporating surface treatments such as nano-texturing and bioactive coatings that enhance cell adhesion and accelerate osseointegration. These innovations reduce fusion time and increase the long-term success of spinal procedures. As implant designs continue to evolve, there is a growing focus on multi-functional implants that not only provide mechanical stability but also deliver biological benefits. Clinical studies have begun to document superior outcomes with these advanced materials, influencing purchasing decisions at hospitals and surgical centers. This technological leap is also being fueled by collaborations between material scientists, biomedical engineers, and orthopedic surgeons who are working together to push the boundaries of what implants can achieve in modern spine care.

Are Shifting Healthcare Infrastructures and Reimbursement Policies Altering Market Accessibility?

The global landscape of healthcare delivery is undergoing profound changes, and these shifts are significantly impacting the adoption of DLIF and XLIF implants. In developed nations such as the United States, Germany, and Japan, the presence of well-established healthcare infrastructure and comprehensive insurance coverage has enabled rapid integration of these implants into routine surgical practice. In the U.S., favorable reimbursement policies under Medicare and private insurers have encouraged hospitals to invest in the specialized training and equipment necessary for DLIF and XLIF procedures. This financial support has made it feasible for even mid-sized healthcare facilities to adopt these advanced techniques. Conversely, in emerging markets across Asia, Latin America, and parts of the Middle East, healthcare systems are at varying stages of development, which can either facilitate or hinder the adoption of these technologies. However, there is a clear trend toward modernization and expansion of healthcare services in these regions. Governments are investing heavily in medical infrastructure, and private hospital chains are proliferating, offering high-end spinal surgeries to a growing middle class. Training programs led by international spine societies and global medtech firms are helping to upskill local surgeons in lateral access fusion techniques, thereby driving market expansion. At the same time, reimbursement models are evolving, with more countries moving toward value-based care that rewards clinical efficacy and cost-efficiency-two hallmarks of DLIF and XLIF. Additionally, the rise of outpatient spinal surgeries, particularly in the U.S. and Western Europe, is accelerating demand for implants that are compatible with shorter, less invasive procedures. The increased focus on bundled payments and episode-based reimbursements is also encouraging hospitals to choose implant solutions that minimize complications and readmissions. These systemic changes are reshaping access to DLIF and XLIF implants, democratizing their availability and expanding their role in the global spine surgery ecosystem.

What’s Truly Powering the Market Expansion for DLIF and XLIF Implants?

The growth in the DLIF and XLIF implants market is driven by several factors that are deeply tied to innovation, demographic shifts, surgical evolution, and end-user expectations. One of the most significant drivers is the increasing prevalence of degenerative spinal conditions and trauma-induced injuries, which are fueling the need for effective and reliable spinal fusion procedures. DLIF and XLIF techniques, known for their minimally invasive nature, are becoming the procedures of choice in these scenarios, and the implants used in them are in growing demand. Technological progress in surgical navigation, robotic assistance, and intraoperative imaging is another critical factor; these tools allow for highly precise implant placement, thereby improving clinical outcomes and surgeon confidence. Equally important is the shift in surgical preferences-orthopedic surgeons and neurosurgeons are increasingly favoring lateral approaches due to their ability to avoid major muscle disruption and reduce hospital stays. On the patient side, there is a rising demand for surgeries that allow quicker recovery, less pain, and minimal scarring, all of which DLIF and XLIF procedures promise when paired with the right implants. The expanding trend of ambulatory surgical centers (ASCs) and same-day discharge options is also fueling demand for implants that support short-duration, high-efficiency procedures. Furthermore, the entry of startups and established medtech companies into this niche is intensifying R&D efforts, leading to more diverse and advanced product offerings tailored for specific patient groups, spinal pathologies, and surgeon preferences. Market players are also focusing on strategic collaborations with hospitals and research institutions to create comprehensive procedural ecosystems that integrate implants, instruments, navigation tools, and training modules. These synergies are streamlining the surgical process and creating value for healthcare providers. Lastly, the growing emphasis on data-driven outcomes and long-term cost-effectiveness is prompting institutions to favor implant systems that demonstrate lower revision rates and better patient satisfaction, cementing the position of DLIF and XLIF implants in the global spinal implants market.

SCOPE OF STUDY:

The report analyzes the DLIF and XLIF Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application, Other Applications); End-Use (Hospitals End-Use, Outpatient Facilities End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alphatec Holdings, Inc. (ATEC Spine)
  • Aurora Spine Corporation
  • B. Braun Melsungen AG
  • Captiva Spine, Inc.
  • Centinel Spine, LLC
  • CoreLink, LLC
  • Curiteva
  • DePuy Synthes (Johnson & Johnson)
  • Exactech, Inc.
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Life Spine, Inc.
  • LDR Holding Corporation
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • SeaSpine Holdings Corporation
  • Spinal Elements, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DLIF and XLIF Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Minimally Invasive Spine Surgeries Throws the Spotlight on DLIF and XLIF Implant Demand
    • Rising Geriatric Population Propels Growth of Lateral Interbody Fusion Procedures
    • Increasing Adoption of Outpatient and Same-Day Spine Surgeries Strengthens Business Case for Minimally Invasive Implants
    • Advancements in 3D-Printed Implant Designs Expand Addressable Market Opportunity for Patient-Specific Solutions
    • Integration with Robotic and Navigation Systems Drives Adoption in High-Precision Surgical Environments
    • Emergence of Biocompatible and Osteoinductive Materials Accelerates Demand for Next-Gen Implant Platforms
    • Shift Toward Value-Based Healthcare Models Spurs Demand for Clinically Effective and Cost-Efficient Implant Solutions
    • Rising Prevalence of Degenerative Disc Disorders Generates Sustained Need for Fusion-Based Therapeutic Interventions
    • Increasing Preference for Lateral Access Approaches Over Traditional Methods Drives Market Realignment
    • Expanding Surgeon Training and Educational Initiatives Sustain Growth in Procedural Volumes
    • Growing Use of AI and Machine Learning in Surgical Planning Tools Enhances Appeal of Implant-Supported Procedures
    • Demand for Shorter Hospital Stays and Quicker Recovery Times Spurs Shift Toward Minimally Invasive Implant Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DLIF and XLIF Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Disc Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spondylolisthesis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Scoliosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION